USSTOCK.TODAY
After-Market
Log in Sign up

ResMed Inc shares rise ahead of earnings as FY2027 growth outlook is lowered

Earnings Whispers ·

RMD Resmed Inc
$246.20 +0.29%
View chart & analysis →
  1. 1ResMed shares have risen nearly 19% since the last report.
  2. 2ResMed revenue consensus is estimated at $1.39 billion.
  3. 3ResMed announced a FY2027 constant currency core growth outlook of 5% to 7%.

So what's the key point?

ResMed shares have recently risen by about 19%. Experts expect revenue to be around $1.39 billion.

Source Earnings Whispers · View original ↗

Related 3-line summaries

Under Armour cuts FY27 revenue outlook on weak demand Medical Device Network +2 · Aug 10Sprout Social beats 2Q adjusted EPS estimate at 26 cents Associated Press +1 · Aug 7Northwest Natural (NWN) Q2 net profit of $600,000 Associated Press +2 · Aug 5
Today's 5 AI picks, all free
Nothing hidden: past picks and how they did against the S&P 500.
See today's picks →
← Back to news